Bibliographic information
GuidelineConsolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach
Year of Publication2021
Issuing InstitutionWHO
Recommendation
Maintained
Treating severe or moderately severe histoplasmosis among people living with HIV: In settings where liposomal amphotericin B is unavailable, deoxycholate amphotericin B, 0.7–1.0 mg/kg, is recommended for two weeks
Recommended in favor
Conditional
Certainty of evidence
Very low
Also Featured In
This recommendation also appears in the following guidelines:
Originally Developed
Guideline
Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
Year2020
InstitutionPan American Health Organization
Guideline
WHO guidelines on the management of advanced HIV disease
Year2025
InstitutionWorld Health Organization